These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2875469)

  • 1. Alpha 2-adrenergic antagonists effect on amphetamine-induced behaviors.
    Luttinger D; Durivage ME
    Pharmacol Biochem Behav; 1986 Jul; 25(1):155-60. PubMed ID: 2875469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy.
    Robertson A; MacDonald C
    Pharmacol Biochem Behav; 1984 Jul; 21(1):97-101. PubMed ID: 6540455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat.
    Dickinson SL; Gadie B; Tulloch IF
    Psychopharmacology (Berl); 1988; 96(4):521-7. PubMed ID: 2907662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine and prazosin slow the rhythm of head movements during focused stereotypy induced by d-amphetamine in rats.
    Fowler SC; Pinkston JW; Vorontsova E
    Psychopharmacology (Berl); 2007 Jun; 192(2):219-30. PubMed ID: 17279374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy.
    Tschanz JT; Rebec GV
    Pharmacol Biochem Behav; 1988 Nov; 31(3):519-22. PubMed ID: 3251235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats.
    Gattaz WF; Schummer B; Behrens S
    J Neural Transm Gen Sect; 1994; 96(3):227-32. PubMed ID: 7826573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications for multiple transmitter mediation of amphetamine-induced stereotypies.
    Cheal M; Kurkulos ME; Silva L
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1305-8. PubMed ID: 6891794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CI-943, a potential antipsychotic agent. I. Preclinical behavioral effects.
    Heffner TG; Downs DA; Meltzer LT; Wiley JN; Williams AE
    J Pharmacol Exp Ther; 1989 Oct; 251(1):105-12. PubMed ID: 2571712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat.
    Martin RS; Secchi RL; Sung E; Lemaire M; Bonhaus DW; Hedley LR; Lowe DA
    Psychopharmacology (Berl); 2003 Jan; 165(2):128-35. PubMed ID: 12404071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
    Delfs JM; Kelley AE
    Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open field study of stereotyped locomotor activity in amphetamine-treated rats.
    Schiørring E
    Psychopharmacology (Berl); 1979; 66(3):281-7. PubMed ID: 119275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the 5-HT3 receptor antagonist ondansetron on amphetamine-induced hyperactivity and stereotypy in rats.
    Shankar RP; Karan RS; Handu SS; Bhargava VK
    Indian J Physiol Pharmacol; 2000 Jul; 44(3):355-8. PubMed ID: 10941627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locomotor stereotypy is produced by methylphenidate and amfonelic acid and reduced by haloperidol but not clozapine or thioridazine.
    Mueller K
    Pharmacol Biochem Behav; 1993 May; 45(1):71-6. PubMed ID: 8100075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metoclopramide potentiates d-amphetamine-induced hypermotility and stereotypy in rat.
    Howard JL; Pollard GT; Craft RM; Rohrbach KW
    Pharmacol Biochem Behav; 1987 May; 27(1):165-9. PubMed ID: 3615538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical antipsychotics, clozapine and sulpiride do not antagonise amphetamine-induced stereotyped locomotion.
    Moore S; Kenyon P
    Psychopharmacology (Berl); 1994 Feb; 114(1):123-30. PubMed ID: 7846194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of para-chlorophenylalanine on amphetamine-induced locomotion and stereotypy.
    Segal DS
    Brain Res; 1976 Nov; 116(2):267-76. PubMed ID: 135600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some central effects of opioid antagonists. Part I.
    Skorupska M; Langwiński R
    Pol J Pharmacol Pharm; 1989; 41(5):401-11. PubMed ID: 2577060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic influence on the potentiation of D-amphetamine and apomorphine-induced rotational behavior by the alpha2-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats.
    Srinivasan J; Schmidt WJ
    J Neural Transm (Vienna); 2005 Sep; 112(9):1223-36. PubMed ID: 15614426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in amphetamine stereotypy following acute lesions of substantia nigra.
    Gonzalez LP
    Life Sci; 1987 Mar; 40(9):899-908. PubMed ID: 3546989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amperozide--a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour.
    Gustafsson B; Christensson E
    Pharmacol Toxicol; 1990; 66 Suppl 1():12-7. PubMed ID: 1968250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.